Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 14, 2020

SELL
$27.44 - $73.84 $776,552 - $2.09 Million
-28,300 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$34.47 - $47.53 $2.38 Million - $3.28 Million
-69,000 Reduced 70.91%
28,300 $1.04 Million
Q2 2019

Aug 14, 2019

SELL
$40.1 - $52.33 $96,240 - $125,592
-2,400 Reduced 2.41%
97,300 $4.53 Million
Q1 2019

May 15, 2019

BUY
$40.11 - $53.57 $4 Million - $5.34 Million
99,700 New
99,700 $4 Million

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $120M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.